Ginkgo Bioworks Holdings, Inc. SEC filings DNA

Ginkgo Bioworks Holdings, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jun 14, 2023. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
10-Q Quarterly report May 6, 2025 Mar 31, 2025
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
DNA (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boston, MA
SEC filer status
Accelerated filer
SEC CIK
1830214
Former names
Soaring Eagle Acquisition Corp. (until Sep 17, 2021); Spinning Eagle Acquisition Corp. (until Jan 4, 2021)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.